The ACP is recognised by the Royal College of Physicians and the Department of Health as the specialty association for medical oncologists.

The executive committee is made up of democratically elected clinicians representing the views and concerns of the membership.

Membership of the ACP gives medical oncologists an independent voice in the affairs of the Royal College of Physicians, the Joint Collegiate Council for Oncology (JCCO) and the Specialty Advisory Committee (SAC), who supervise training and accreditation.

This workshop features talks on the management of toxicity resulting from immunotherapy, the prospects of combined therapies, and discussions on finance and the future of immunotherapy.